Prescription drug · NDA
ATROPEN Auto-Injector (atropine) NDC 11704-106
Atropine 2 mg/.7mL · Injection · Intramuscular · Meridian Medical Technologies LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11704-106-01 | 11704010601 | .7 mL in 1 SYRINGE, PLASTIC (11704-106-01)Marketed from Jun 19, 2003 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ATROPEN Auto-Injector
- Generic name (nonproprietary)
- atropine
- Active ingredients
- Atropine — 2 mg/.7mL
- Dosage form
- Injection
- Route
- Intramuscular
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 017106
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 11704-106_f1736bb6-219c-48dd-969d-f26f6fbad350SPL ID f1736bb6-219c-48dd-969d-f26f6fbad350SPL set ID e2d4307d-da8f-49f5-aac0-02355dd9ffb7RxCUI 1190536, 1190538, 1190540, 1190542, 1190608, 1190611, 1190614, 1190620UNII 7C0697DR9IUPC 0311704101017
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N411704010601followed by a unit qualifier and the quantityPackage 11704-0106-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ATROPEN is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients. ATROPEN is a cholinergic muscarinic antagonist indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 017106
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ATROPEN Auto-Injectoratropine | Atropine 2 mg/.7mL | InjectionIntramuscular | Meridian Medical Technologies LLC | 11704-101 |
| ATROPEN Auto-Injectoratropine | Atropine .5 mg/.7mL | InjectionIntramuscular | Meridian Medical Technologies LLC | 11704-104 |
| ATROPEN Auto-Injectoratropine | Atropine 1 mg/.7mL | InjectionIntramuscular | Meridian Medical Technologies LLC | 11704-105 |
| ATROPEN Auto-Injectoratropine | Atropine .25 mg/.3mL | InjectionIntramuscular | Meridian Medical Technologies LLC | 11704-107 |